Topiramate in opiate withdrawal

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 6, 2002, Pages 1221-1223

  Zullino, Daniele F ^a   Cottier, Anne Claude ^a   Besson, Jacques ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

Author keywords

Anticonvulsant; Narcotics; Opioid related disorders; Substance withdrawal syndrome

Indexed keywords

AMPA RECEPTOR; GLUTAMIC ACID; OPIATE; TOPIRAMATE;

ADULT; ARTICLE; CASE REPORT; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HUMAN; LOCUS CERULEUS; MALE; WITHDRAWAL SYNDROME;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANTICONVULSANTS; CLONIDINE; FEMALE; FRUCTOSE; HEROIN DEPENDENCE; HUMANS; LIVER FUNCTION TESTS; MALE; OPIOID-RELATED DISORDERS; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0036774375     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00251-8     Document Type: Article

References (9)

1. American Psychiatric Association Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am. J. Psychiatry. 152:1995;43-44. Supplement.
2. Bertschy G., Bryois C., Bondolfi G., Velardi A., Budry P., Dascal D., Martinet C., Baettig D., Baumann P. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine. Pharmacol. Res. 35:1997;451-456.
3. Chatterjee C.R., Ringold A.L. A case report of reduction in alcohol craving and protection against alcohol withdrawal by gabapentin. J. Clin. Psychiatry. 60:1999;617.
4. Jackson A., Mead A.N., Stephens D.N. Behavioural effects of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacol. Ther. 88:2000;59-76.
5. Langtry H.D., Gillis J.C., Davis R. Topiramate - a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs. 54:1997;752-773.
6. Mendelson J.H., Mello N.K. Management of cocaine abuse and dependence. N. Engl. J. Med. 334:1996;965-972.
7. Myrick H., Malcolm R., Brady K.T. Gabapentin treatment of alcohol withdrawal. Am. J. Psychiatry. 155:1998;1632.
8. Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology. 13:1995;295-300.
9. Teter C.J., Early J.J., Gibbs C.M. Treatment of affective disorder and obesity with topiramate. Ann. Pharmacother. 34:2000;1262-1265.